What's On News October 2022 Hereditary Breast and Ovarian cancer testing now offered routinely at Mater Pathology

News

Hereditary Breast and Ovarian cancer testing now offered routinely at Mater Pathology

Monday 10 October 2022

Mater Pathology is proud to be able to offer germline testing for hereditary breast cancer and ovarian cancer syndrome with estimated turnaround time for results of 20 business days for routine, and 10 business days for urgent testing, from receipt of sample in the laboratory.

Purchased through Mater Foundation with funds raised by the 2021 RACQ International Women’s Day Fun Run for Mater Chicks in Pink, the Thermo Fisher AB3500XL Genetic analyser removes the reliance on outsourced testing, where results could take up to 4-5 months to return.

Testing can be requested by specialists such as oncologists, breast surgeons or clinical geneticists, and are often covered by Medicare when the conditions are met.  These conditions can be found on our information flyer (download here), or via the Medicare Benefits Schedule online.

Pre- and post-test counselling should be provided or arranged by the requesting specialist.

For more information on this or any other testing provided by Mater Pathology, please visit the website, or contact 07 3163 8500.